Partnering

We are constantly seeking out strategic partnerships with companies and research institutions that complement SOM Biotech’s discovery and development expertise. SOM Biotech business model is based in out licensing its own programs and establishing joint-venture agreements for the development of repositioned drugs. In licensing opportunities to enrich our research pipeline are also being assessed.

OUT LICENSING

Early asset licensing before Clinical PoC or Late licensing after Clinical PoC.

JOINT-VENTURE

Co-development agreements: Pharma/Biotech companies or public institutions interested in finding new indications for a specific drug/identifying marketed drugs for a specific disease.

IN LICENSING

Pre-Clinical and Early Clinical Stage repurposing programs.

We welcome inquiries from biopharmaceutical companies/research institutions wishing to discuss potential collaborations with us. Partnerships are an important part of SOM Biotech growth strategy.

To inquire about partnering opportunities with SOM Biotech, please send an email to our business development team bd@sombiotech.com or dial +34 934020150 (Direct number).